Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,150 | 6 | 75.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $525.00 | 2 | 12.5% |
| Food and Beverage | $305.30 | 6 | 7.3% |
| Honoraria | $200.00 | 1 | 4.8% |
| Education | $18.09 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,283 | 7 | $0 (2024) |
| GENZYME CORPORATION | $275.00 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $250.00 | 1 | $0 (2022) |
| Daiichi Sankyo Inc. | $200.00 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $80.53 | 3 | $0 (2023) |
| PFIZER INC. | $62.00 | 1 | $0 (2017) |
| Amgen Inc. | $30.16 | 1 | $0 (2020) |
| Merck Sharp & Dohme LLC | $18.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,168 | 7 | AstraZeneca Pharmaceuticals LP ($3,150) |
| 2023 | $230.85 | 2 | Daiichi Sankyo Inc. ($200.00) |
| 2022 | $250.00 | 1 | Alexion Pharmaceuticals, Inc. ($250.00) |
| 2020 | $30.16 | 1 | Amgen Inc. ($30.16) |
| 2019 | $49.68 | 2 | Janssen Pharmaceuticals, Inc ($49.68) |
| 2018 | $407.61 | 2 | GENZYME CORPORATION ($275.00) |
| 2017 | $62.00 | 1 | PFIZER INC. ($62.00) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 07/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2023 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $200.00 | General |
| 02/10/2022 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| 07/11/2020 | Amgen Inc. | Vectibix (Biological) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: Oncology | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2018 | GENZYME CORPORATION | ELITEK (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $275.00 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $132.61 | General |
| 07/08/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $62.00 | General |
| Category: DERMATOLOGY | ||||||
About Dr. Jennifer Wu, MD
Dr. Jennifer Wu, MD is a Hematology & Oncology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417997412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Wu, MD has received a total of $4,198 in payments from pharmaceutical and medical device companies, with $3,168 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($3,150).
Practice Information
- Specialty Hematology & Oncology
- Location Brooklyn, NY
- Active Since 06/07/2006
- Last Updated 11/27/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417997412
Products in Payments
- IMFINZI (Biological) $2,100
- TAGRISSO (Drug) $525.00
- Truqap (Drug) $525.00
- ELITEK (Drug) $275.00
- XARELTO (Drug) $80.53
- EUCRISA (Drug) $62.00
- Vectibix (Biological) $30.16
- WELIREG (Drug) $18.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brooklyn
Perry Cook, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Yiwu Huang, Md, MD
Hematology & Oncology — Payments: $268,275
Dr. Ilya Blokh, M.d, M.D
Hematology & Oncology — Payments: $191,276
Songchuan Guo, M.d, M.D
Hematology & Oncology — Payments: $106,907
Yiqing Xu, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $51,145
Dr. Azriel Hirschfeld, M.d, M.D
Hematology & Oncology — Payments: $48,699